AC Immune SA annual operating expenses
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AC Immune SA Operating Expenses Growth & History (ACIU)
AC Immune SA's operating expenses was CHF72.9M for fiscal 2025.
View full AC Immune SA company overviewAC Immune SA annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF72.9M | −CHF6.8M | −8.53% |
| 2024 | 2024-12-31 | CHF79.7M | CHF11.3M | +16.46% |
| 2023 | 2023-12-31 | CHF68.4M | −CHF6.4M | −8.50% |
| 2022 | 2022-12-31 | CHF74.8M | −CHF4.2M | −5.35% |
| 2021 | 2021-12-31 | CHF79.0M | CHF2.3M | +3.02% |
| 2020 | 2020-12-31 | CHF76.7M | CHF10.8M | +16.34% |
| 2019 | 2019-12-31 | CHF65.9M | CHF9.5M | +16.75% |
| 2018 | 2018-12-31 | CHF56.5M | CHF13.7M | +31.94% |
| 2017 | 2017-12-31 | CHF42.8M | CHF9.1M | +27.10% |
| 2016 | 2016-12-31 | CHF33.7M | CHF13.2M | +64.52% |
| 2015 | 2015-12-31 | CHF20.5M | — | — |
AC Immune SA quarterly operating expenses
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q3.21
Q2.22
Q3.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF13.9M | −CHF6.8M | −32.73% |
| Q1 2026 | 2026-03-31 | CHF15.9M | — | — |
| Q4 2025 | 2025-12-31 | CHF14.7M | — | — |
| Q3 2025 | 2025-09-30 | CHF16.6M | — | — |
| Q2 2025 | 2025-06-30 | CHF20.7M | −CHF954,000 | −4.41% |
| Q2 2024 | 2024-06-30 | CHF21.6M | CHF4.6M | +27.00% |
| Q2 2023 | 2023-06-30 | CHF17.0M | −CHF2.8M | −14.16% |
| Q3 2022 | 2022-09-30 | CHF17.4M | −CHF2.9M | −14.23% |
| Q2 2022 | 2022-06-30 | CHF19.9M | — | — |
| Q3 2021 | 2021-09-30 | CHF20.3M | — | — |
| Q4 2018 | 2018-12-31 | CHF15.9M | CHF2.7M | +20.07% |
| Q3 2018 | 2018-09-30 | CHF14.5M | CHF3.8M | +35.11% |
| Q2 2018 | 2018-06-30 | CHF13.6M | CHF4.6M | +50.99% |
| Q1 2018 | 2018-03-31 | CHF12.8M | CHF2.9M | +29.88% |
| Q4 2017 | 2017-12-31 | CHF13.2M | — | — |
| Q3 2017 | 2017-09-30 | CHF10.7M | — | — |
| Q2 2017 | 2017-06-30 | CHF9.0M | — | — |
| Q1 2017 | 2017-03-31 | CHF9.8M | — | — |
AC Immune SA operating expenses trends
Over the last five fiscal years, AC Immune SA's operating expenses decreased from CHF76.7M to CHF72.9M, a change of −CHF3.8M. The latest reported quarter, Q2 2026, shows CHF13.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA source filings ↗